SCHEMBL567665

SCHEMBL567665

O=C1COC(=O)[C@H](COCc2ccccc2)O1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
AKT1 P31749 1/20 0.48
TAAR1 Q96RJ0 1/20 0.43
TSHR P16473 2/20 0.40
CYP3A4 P08684 3/20 0.39
MAPT P10636 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSK P43235 1/20 0.38
PTPN1 P18031 1/20 0.38
CDC25B P30305 1/20 0.38
OPRM1 P35372 1/20 0.38
KCNH2 Q12809 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL567091 1.00 LMNA (0.49) LMNAAKT1TAAR1TSHRCYP3A4
SCHEMBL15239316 0.86 TAAR1 (0.41) LMNAAKT1TAAR1TSHRMAOA
SCHEMBL2610008 0.82 LMNA (0.54) LMNAAKT1TAAR1TSHRCTSL
SCHEMBL2181334 0.82 LMNA (0.54) LMNAAKT1TAAR1TSHRCTSL
SCHEMBL5501059 0.80 CTRB1 (0.42) TAAR1TSHRMAOBHTT
SCHEMBL12537283 0.78 LMNA (0.50) LMNAAKT1TAAR1TSHRCTSL
SCHEMBL567327 0.78 GLA (0.47) CDC25B
SCHEMBL536617 0.78 GLA (0.47) CDC25B
SCHEMBL7259274 0.77 LMNA (0.49) LMNACYP2C19MAOAMAOBBCHE
SCHEMBL567024 0.76 ALDH1A1 (0.43) LMNACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199794-A1 Monomers and Polymers with Pendant Aspirin and Compositions and Methods Thereof UNIVERSITY OF MASSACHUSETTS 2024-06-20 US disclosed
WO-2022221026-A1 MONOMERS AND POLYMERS WITH PENDANT ASPIRIN, AND COMPOSITIONS AND METHODS THEREOF UNIVERSITY OF MASSACHUSETTS (US) 2022-10-20 WO disclosed
US-20120035341-A1 PROCEDE DE POLYMERISATION PAR VOIE CATALYTIQUE DE 1,4-DIOXANES-2,5-DIONES ET LES POLYMERES CORRESPONDANTS MINASOLVE (FR) 2012-02-09 US disclosed
WO-2010123349-A1 SYSTEM FOR CONTROLLED DRUG DELIVERY COMPRISING BIODEGRADABLE POLYMER MICROPARTICLES UNIVERSITEIT UTRECHT HOLDING B.V. (NL) 2010-10-28 WO disclosed
WO-2010100390-A1 CATALYTIC POLYMERIZATION METHOD FOR 1,4-DIOXANE-2,5-DIONES, AND CORRESPONDING POLYMERS MINASOLVE (FR) 2010-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199794-A1 Monomers and Polymers with Pendant Aspirin and Compositions and Methods Thereof PTGIS, PTGS1, PTGIR LMNA 3482/4885AKT1 2976/4885TAAR1 2084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.